Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LAI”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableLooking for participantsNCT06046079
What this trial is testing

Predictors of Health Service Utilizations Among Key Population in Washington DC

Who this might be right for
Pre-exposure ProphylaxisHIVHealth Behavior
Us Helping Us, People Into Living, Inc. 100
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Testing effectiveness (Phase 2)Study completedNCT03038178
What this trial is testing

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Who this might be right for
Mycobacterium Infections, NontuberculousMycobacteria, Atypical
Kevin Winthrop 30
Post-approval studies (Phase 4)Study completedNCT03376763
What this trial is testing

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Who this might be right for
SchizophreniaAntipsychoticsLong-Acting Injection+2 more
Korea Otsuka Pharmaceutical Co., Ltd. 201
Large-scale testing (Phase 3)Study completedNCT02628600
What this trial is testing

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

Who this might be right for
NTM Lung Infection Due to MAC
Insmed Incorporated 163
Early research (Phase 1)Looking for participantsNCT07484204
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Anxo Pharmaceutical Co., Ltd. 48
Not applicableEnrolling By InvitationNCT06488846
What this trial is testing

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Who this might be right for
HIV Infections
University of California, San Francisco 1,000
Large-scale testing (Phase 3)UnknownNCT05204394
What this trial is testing

Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

Who this might be right for
HIV-1-infection
Viriom 438
Early research (Phase 1)Study completedNCT04709224
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 37
Early research (Phase 1)Looking for participantsNCT07061288
What this trial is testing

Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Who this might be right for
Schizophrenia
Bristol-Myers Squibb 131
Early research (Phase 1)Study completedNCT06558643
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Who this might be right for
Malaria,Falciparum
Medicines for Malaria Venture 32
Early research (Phase 1)WithdrawnNCT05119894
What this trial is testing

A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd.
Not applicableEnrolling By InvitationNCT07130500
What this trial is testing

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Who this might be right for
Schizophrenia DisorderSchizoaffective DisorderBipolar Disorder (BD)+1 more
Stanford University 1,000
Not applicableLooking for participantsNCT07116629
What this trial is testing

Catch A Vibe - 24-00864

Who this might be right for
Health-Related Social Needs
NYU Langone Health 343
Post-approval studies (Phase 4)UnknownNCT03080194
What this trial is testing

The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Maosheng Fang 150
Early research (Phase 1)Not Yet RecruitingNCT07548021
What this trial is testing

Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda

Who this might be right for
Malaria (Plasmodium Falciparum)Malaria FalciparumMalaria Infection+4 more
Medicines for Malaria Venture 80
Large-scale testing (Phase 3)Study completedNCT01888107
What this trial is testing

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen-Cilag S.p.A. 347
Early research (Phase 1)Study completedNCT00821600
What this trial is testing

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Who this might be right for
Psychotic DisordersSchizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24
Not applicableUnknownNCT03757637
What this trial is testing

Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients

Who this might be right for
Differentiated Thyroid Cancer
National Taiwan University Hospital 380
Post-approval studies (Phase 4)Study completedNCT03408873
What this trial is testing

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Who this might be right for
Bipolar DisorderMedication AdherenceMedication Non Adherence
Martha Sajatovic 30
Next Page